717107-32-9 Usage
Uses
Used in Organic Synthesis:
2-(2-Carboxyethyl)phenylboronic acid serves as a versatile building block in organic synthesis, contributing to the creation of a wide array of pharmaceuticals, agrochemicals, and organic materials. Its unique structure allows for the development of new compounds with specific properties.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 2-(2-Carboxyethyl)phenylboronic acid is utilized for drug design and delivery. Its capacity to form reversible covalent bonds with diols makes it a promising candidate for the development of drugs with targeted actions and improved efficacy.
Used in Biochemical and Biological Research:
The water solubility of 2-(2-Carboxyethyl)phenylboronic acid, due to the presence of the carboxyethyl group, facilitates its manipulation in aqueous environments. This feature is particularly beneficial for biochemical and biological research, where water solubility is often a prerequisite for studying the interactions of compounds with biological systems.
Check Digit Verification of cas no
The CAS Registry Mumber 717107-32-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,1,7,1,0 and 7 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 717107-32:
(8*7)+(7*1)+(6*7)+(5*1)+(4*0)+(3*7)+(2*3)+(1*2)=139
139 % 10 = 9
So 717107-32-9 is a valid CAS Registry Number.
717107-32-9Relevant academic research and scientific papers
Phenylboronic Acid Derivatives as Validated Leads Active in Clinical Strains Overexpressing KPC-2: A Step against Bacterial Resistance
Celenza, Giuseppe,Vicario, Mattia,Bellio, Pierangelo,Linciano, Pasquale,Perilli, Mariagrazia,Oliver, Antonio,Blazquez, Jesús,Cendron, Laura,Tondi, Donatella
supporting information, p. 713 - 724 (2018/02/26)
The emergence and dissemination of multidrug resistant (MDR) pathogens resistant to nearly all available antibiotics poses a significant threat in clinical therapy. Among them, Klebsiella pneumoniae clinical isolates overexpressing KPC-2 carbapenemase are
PHTHALAZINE DERIVATIVES PHOSPHODIESTERASE 4 INHIBITORS
-
Page 23, (2008/06/13)
Compounds of formula (I) wherein R is methyl or difluoromethyl; X is a methylene group, ethylene, -CH=CH-, -O-CH2-, -O-(CH2)2, -O-(CH2)3-, -NH-SO2-(CH2)3-, -NH-CO-(CH2)2-, -NH-CO-(CH2)3-, N-(ethane-sulfonylamino) pyperazinyl, the N-oxidised derivatives of -CH2-CH-NH2| the compounds of formula I and the pharmaceutically acceptable salts thereof are described.The compounds of formula I are PDE 4 inhibitors.
